| Oxidative stress in the pathogenesis of Crohn’s disease and the interconnection with immunological response, microbiota, external environmental factors, and epigenetics E Alemany-Cosme, E Sáez-González, I Moret, B Mateos, M Iborra, P Nos, ... Antioxidants 10 (1), 64, 2021 | 98 | 2021 |
| Influence of vitamin D deficiency on inflammatory markers and clinical disease activity in IBD patients P López-Muñoz, B Beltrán, E Sáez-González, A Alba, P Nos, M Iborra Nutrients 11 (5), 1059, 2019 | 61 | 2019 |
| Fecal calprotectin pretreatment and induction infliximab levels for prediction of primary nonresponse to infliximab therapy in Crohn’s disease B Beltrán, M Iborra, E Sáez-González, MR Marqués-Miñana, I Moret, ... Digestive Diseases 37 (2), 108-115, 2019 | 46 | 2019 |
| A nomogram combining fecal calprotectin levels and plasma cytokine profiles for individual prediction of postoperative Crohn’s disease recurrence E Cerrillo, I Moret, M Iborra, J Pamies, D Hervás, L Tortosa, ... Inflammatory Bowel Diseases 25 (10), 1681-1691, 2019 | 35 | 2019 |
| Serum adalimumab levels predict successful remission and safe deintensification in inflammatory bowel disease patients in clinical practice M Aguas Peris, V Bosó, B Navarro, MR Marqués-Miñana, G Bastida, ... Inflammatory bowel diseases 23 (8), 1454-1460, 2017 | 33 | 2017 |
| Opioid-induced lower esophageal sphincter dysfunction ES González, VO Bellver, FCD Jaime, JAO Cortés, VG Gil Journal of neurogastroenterology and motility 21 (4), 618, 2015 | 33 | 2015 |
| Identification of epigenetic methylation signatures with clinical value in Crohn's disease I Moret-Tatay, E Cerrillo, E Sáez-González, D Hervás, M Iborra, ... Clinical and translational gastroenterology 10 (10), e00083, 2019 | 29 | 2019 |
| Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT) E Sáez‐González, C Vinaixa, F San Juan, V Hontangas, S Benlloch, ... Liver International 38 (6), 1022-1027, 2018 | 29 | 2018 |
| Iberogast-induced severe hepatotoxicity leading to liver transplantation E Sáez-González, I Conde, FC Díaz-Jaime, S Benlloch, M Prieto, ... Official journal of the American College of Gastroenterology| ACG 111 (9 …, 2016 | 29 | 2016 |
| A concise review of opioid-induced esophageal dysfunction: is this a new clinical entity? V Ortiz, M García-Campos, E Sáez-González, P Delpozo, V Garrigues Diseases of the Esophagus 31 (5), doy003, 2018 | 26 | 2018 |
| Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis FC Díaz, E Sáez-González, S Benlloch, D Álvarez-Sotomayor, I Conde, ... Annals of hepatology 15 (6), 939-943, 2017 | 25 | 2017 |
| Decreased esophageal sensitivity to acid in morbidly obese patients: a cause for concern? V Ortiz, D Alvarez-Sotomayor, E Sáez-González, FC Díaz-Jaime, M Iborra, ... Gut and Liver 11 (3), 358, 2017 | 20 | 2017 |
| The combination of granulocyte‐monocyte apheresis and vedolizumab: a new treatment option for ulcerative colitis? I Rodríguez‐Lago, JM Benítez, L Sempere, E Sáez‐González, ... Journal of Clinical Apheresis 34 (6), 680-685, 2019 | 17 | 2019 |
| Single-operator cholangiopancreatoscopy in pancreatobiliary diseases: clinical experience in a tertiary referral hospital V Pons-Beltrán, N Alonso-Lázaro, R Mansilla-Vivar, E Sáez-González, ... Revista Española de Enfermedades Digestivas 110 (12), 748-754, 2018 | 16 | 2018 |
| Immunological mechanisms of adsorptive cytapheresis in inflammatory bowel disease E Sáez-González, I Moret, D Alvarez-Sotomayor, FC Díaz-Jaime, ... Digestive Diseases and Sciences 62 (6), 1417-1425, 2017 | 15 | 2017 |
| Utilización del cuestionario PRIME-MD® para la detección de trastornos mentales en mujeres inmigrantes iberoamericanas e hispanohablantes M Herrero, E González, T Valverde, L Caballero Med. clín (Ed. impr.), 716-717, 2001 | 15 | 2001 |
| Epigenetics of inflammatory bowel disease: unraveling pathogenic events B Mateos, C Palanca-Ballester, E Saez-Gonzalez, I Moret, A Lopez, ... Crohn's & Colitis 360 1 (2), otz017, 2019 | 14 | 2019 |
| Bases for the adequate development of nutritional recommendations for patients with inflammatory bowel disease E Sáez-González, B Mateos, P López-Muñoz, M Iborra, I Moret, P Nos, ... Nutrients 11 (5), 1062, 2019 | 13 | 2019 |
| Sucrosomial iron supplementation for the treatment of iron deficiency anemia in inflammatory bowel disease patients refractory to oral iron treatment G Bastida, C Herrera-de Guise, A Algaba, Y Ber Nieto, JM Soares, ... Nutrients 13 (6), 1770, 2021 | 12 | 2021 |
| Plasma oncostatin m, TNF-α, il-7, and il-13 network predicts crohn’s disease response to infliximab, as assessed by calprotectin log drop B Mateos, E Sáez-González, I Moret, D Hervás, M Iborra, E Cerrillo, ... Digestive Diseases 39 (1), 1-9, 2021 | 11 | 2021 |
